Search clinical trials for: Doublet (RAD001 and LBH589)

Total 1424 results

Beijing Friendship Hospital
Zhejiang Cancer Hospital; Peking University Third Hospital

Unknown

Biodegradable Stenting Anastomoses Versus Double-layer Hand Sutures for Reconstruction in Intestinal Anastomosis

Crohn Disease | Colonic Neoplasms | Diverticulosis, Colonic

China
Novartis Pharmaceuticals

Completed

Dose Finding Study of RAD001 (Everolimus, Afinitor®) in Combination With BEZ235 in Patients With Advanced Solid Tumors

Metastatic Renal Cell Carcinoma | Advanced Solid Tumors | Metastatic Breast Cancer

Spain, Belgium, Italy, France, United States, New Zealand, United Kingdom
Chinese University of Hong Kong

Completed

Gastric Cancer RAD001 Study

Gastric Cancer

Hong Kong
Memorial Sloan Kettering Cancer Center
Novartis Pharmaceuticals

Completed

Radiation Therapy (IMRT) + RAD001 (Everolimus) + Cisplatin for Patients With Head and Neck Cancer

Head and Neck Cancer

United States
Assistance Publique - Hôpitaux de Paris

Completed

Efficacy and Safety Study of RAD001 in the Growth of the Vestibular Schwannoma(s) in Neurofibromatosis 2 (NF2) Patients (AFINF2)

Neurofibromatosis 2

France
M.D. Anderson Cancer Center
Novartis Pharmaceuticals; BTG International Inc.

Withdrawn

Phase 1 TheraSphere + Everolimus With Neuroendocrine Tumors (NETs) + Liver Only or Liver Dominant Disease

Liver Cancer
National University Hospital, Singapore

Terminated

A Study of TS-1, Cisplatin (CDDP) and RAD001 (Everolimus)

Cancer

Singapore
Dana-Farber Cancer Institute
Novartis Pharmaceuticals

Completed

Everolimus for Cancer With TSC1 or TSC2 Mutation

Tuberous Sclerosis Complex | TSC1 | TSC2 | MTOR

United States
Beth Israel Deaconess Medical Center
Dana-Farber Cancer Institute; Novartis Pharmaceuticals

Completed

Dose Escalation Followed by Study of RAD001 in Combination With Trastuzumab in HER2-Positive Metastatic Breast Cancer

Breast Cancer

United States
Novartis Pharmaceuticals

Completed

Safety and Efficacy of RAD001 (Everolimus) Monotherapy Plus Best Supportive Care in Patients With Advanced Gastric Cancer (AGC) (GRANITE-1)

Advanced Gastric Cancer

China, United States, Belgium, France, Taiwan, United Kingdom, Canada, Spain, Italy, Australia, Russian Federation, Thailand, Korea, Republic of, Israel, Germany, Peru, Argentina, Japan, Hong Kong, New Zealand, Mexico, Netherlands
Seoul National University Hospital

Completed

RAD001 in Pheochromocytoma or Nonfunctioning Carcinoid (PheoCarcRAD001)

Pheochromocytoma | Extra-adrenal Paraganglioma | Non-functioning Carcinoid

Korea, Republic of
Novartis Pharmaceuticals

Recruiting

CINC424A2X01B Rollover Protocol

Acute Myeloid Leukemia | Primary Myelofibrosis | Polycythemia Vera | Thalassemia | Graft Versus Host Disease

Korea, Republic of, Italy, Belgium, Japan, Germany, Australia, Bulgaria, Chile, China, Denmark, Greece, Hungary, Israel, Lebanon, Poland, Portugal, Russian Federation, Slovakia, South Africa, Spain, Sweden, Thailand, India, Mexico, Turkey, Fran...
Novartis Pharmaceuticals

Completed

A Phase Ib/IIb, Open-label, Multi-center, Study of Oral Panobinostat Administered With 5-Azacitidine (in Adult Patients With Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML), or Acute Myeloid Leukemia (AML).

Acute Myeloid Leukemia | Myelodysplastic Syndromes | Chronic Myelomonocytic Leukemia

Belgium, Hungary, Spain, Germany, Canada, Switzerland, Thailand, Korea, Republic of, United Kingdom, Italy, Austria, Sweden, France, United States
Washington University School of Medicine

Completed

LBH589 Plus Decitabine for Myelodysplastic Syndromes (MDS) or Acute Myeloid Leukemia (AML)

Myelodysplastic Syndromes | Leukemia, Myeloid, Acute

United States
Shanghai Refreshgene Technology Co., Ltd.

Recruiting

Safety and Efficacy of RRG001 Gene Therapy in Subjects With Neovascular Age-related Macular Degeneration (nAMD)

Neovascular Age-related Macular Degeneration

China
Shanghai Junshi Bioscience Co., Ltd.

Completed

Safety, Tolerability, Pharmacokinetics & Pharmacodynamics of Toripalimab for Patients With Recurrent Malignant Lymphoma

Malignant Lymphoma

China
Shanghai Junshi Bioscience Co., Ltd.

Unknown

Safety, Tolerability, Pharmacokinetics & Pharmacodynamics of an Anti-PD-1 mAb for Patients With Advanced Solid Tumors

Lymphoma | Lung Cancer

China
Shanghai Junshi Bioscience Co., Ltd.

Completed

The Pharmacokinetics and Safety of Single-dose and Parallel Comparisons in Patients With NSCLC Treated With JS001

NSCLC

China
Hospital Clinic of Barcelona

Not yet recruiting

Lateral Invagination of the Colorectal Anastomosis by Double Stapling

Anastomotic Leak | Sigmoid Diseases
Suzhou Suncadia Biopharmaceuticals Co., Ltd.

Not yet recruiting

A Study of SHR-A1921 With or Without Carboplatin in Subjects With Ovarian Cancer

Ovarian Cancer
NYU Langone Health
Novartis Pharmaceuticals; The Children's Tumor Foundation

Completed

Phase II Study of Everolimus (RAD001) in Children and Adults With Neurofibromatosis Type 2

Neurofibromatosis Type II

United States
Dana-Farber Cancer Institute
Novartis; Brigham and Women's Hospital

Terminated

RAD001 With Weekly Cisplatin and Radiation Therapy in Patients With Locally Advanced Head and Neck Cancer

Head and Neck Cancer

United States
Emory University
Genentech, Inc.; Novartis Pharmaceuticals

Completed

Phase II Trial of EVEROLIMUS ± Trastuzumab in Hormone-Refractory Metastatic Breast Cancer

Breast Cancer

United States
Shadia Jalal
Novartis; Amgen

Completed

Study of RAD001 + AMG479 for Patients With Advanced Solid Tumors

Neoplasm Metastases

United States
Charite University, Berlin, Germany
Novartis Pharmaceuticals; KKS Netzwerk

Unknown

Everolimus (RAD001) and Carboplatin in Pretreated Metastatic Breast Cancer

Breast Cancer

Germany
Relife S.r.l.

Completed

Clinical and Instrumental Evaluation on Definisse Threads (FREE)

Face

Italy
Chiang Mai University

Completed

The Efficacy of Plasmapheresis and Double Filtration Plasmapheresis (DFPP) in Kidney Transplant

Kidney Transplant Rejection | Kidney Replacement | Plasmapheresis
Universidade Estadual de Ponta Grossa
Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.

Completed

Effect of Increased Improve Time on Adhesive System (RCT)

Clinical Trial

Brazil
Southern Europe New Drug Organization
Novartis Pharmaceuticals

Completed

LBH Phase II in Small Cell Lung Cancer (SCLC)

Small Cell Lung Carcinoma

Germany, Italy
Laboratory of Movement, Condorcet, Tournai, Belgium

Completed

Effect of a Modified Oxygen Mask Associated to Nasal Prongs During a High Flow Oxygenation Method

Oxygen Inhalation Therapy

Belgium
Rejuven Dermaceutical Co., Ltd.

Completed

RJV001 Study in Adults Receiving Abdominoplasty

Submental Fat (SMF) | Double Chin

United States
BeiGene

Recruiting

A Study to Evaluate LBL-007 in Combination With Tislelizumab Plus Chemotherapy in Participants With Unresectable Locally Advanced or Metastatic Esophageal Squamous Cell Carcinoma

Esophageal Cancer | Esophageal Squamous Cell Carcinoma | Esophageal Squamous Cell Carcinoma by AJCC V8 Stage

China, Taiwan, Korea, Republic of, Thailand
Novartis Pharmaceuticals

Completed

A Placebo-controlled Study of Efficacy & Safety of 2 Trough-ranges of Everolimus as Adjunctive Therapy in Patients With Tuberous Sclerosis Complex (TSC) & Refractory Partial-onset Seizures (EXIST-3)

Tuberous Sclerosis Complex-associated Refractory Seizures

United States, Colombia, Belgium, France, Japan, Taiwan, Turkey, Spain, Thailand, Korea, Republic of, Australia, Hungary, United Kingdom, Canada, Norway, Germany, Italy, Russian Federation, Denmark, Argentina, Netherlands, Greece, P... and more
Istituto Clinico Humanitas

Not yet recruiting

Outcomes of Transanal Tran-section and Single-stapled (TTSS) Ileal Pouch-Anal Anastomosis (TTSS-Pouch)

Ulcerative Colitis

Italy
Beijing Jishuitan Hospital

Recruiting

Combined Microfracture Procedure Promotes Tendon Healing

Full Rotator Cuff Tear | Microfracture Procedure | Double Raw Repair

China
Northwestern University

Recruiting

DREAM: Double Lung Transplant REgistry Aimed for Lung-limited Malignancies (DREAM)

Lung Cancer | Lung Transplant | Bilateral Cancer

United States
Yu Qin

Active, not recruiting

An Investigator Initiated, Randomized, Double-blinded, Placebo-controlled Clinical Trial to Evaluate the Safety, Immunogenicity and Efficacy of the Recombinant Two-component COVID-19 Vaccine (CHO Cell) in Adults Aged 18 Years and Older

Prevention of COVID-19 Caused by SARS-CoV-2

China
Adrià Jorba García

Completed

The Double Factor Technique: a Computer-guided Implant Surgery Technique for Fully Edentulous Patients (DoubleFactor)

Dental Implants | Surgery, Computer-Assisted

Spain
Ajou University School of Medicine

Completed

Fiberoptic Bronchoscope of Double Lumen Tube and Single Lumen Tube in Patients With Semi-regid Neck Collar.

Thoracic Diseases | Intubation;Difficult

Korea, Republic of
Ajou University School of Medicine

Completed

Insertion Time Over Fiberoptic Bronchoscope of Double Lumen Tube and Single Lumen Tube

Intubation;Difficult

Korea, Republic of
Novartis Pharmaceuticals

Completed

Everolimus Plus Best Supportive Care vs Placebo Plus Best Supportive Care in the Treatment of Patients With Advanced Neuroendocrine Tumors (GI or Lung Origin) (RADIANT-4)

Neuroendocrine Tumors | Advanced NET of GI Origin | Advanced NET of Lung Origin

United States, Colombia, Italy, Taiwan, United Kingdom, Belgium, Czechia, Germany, Japan, Saudi Arabia, Canada, Netherlands, Spain, Korea, Republic of, Lebanon, Austria, China, Greece, South Africa, Thailand, Hungary, Turkey, Poland, ... and more
Case Comprehensive Cancer Center
National Cancer Institute (NCI)

Terminated

RAD001(Everolimus) in Treating Patients With Myelodysplastic Syndromes

Myelodysplastic Syndromes

United States
Restorbio Inc.

Active, not recruiting

Dose Finding Study to Determine if BEZ235 Alone or in Combination With RAD001 Decreases the Incidence of Respiratory Tract Infections in the Elderly

Respiratory Tract Infections

United States
Novartis Pharmaceuticals

Completed

Renal Safety of Everolimus in Addition to Cyclosporine Microemulsion in Cardiac Transplant Recipients.

Cardiac Transplantation
Novartis Pharmaceuticals

Completed

This is a Two-year Follow-up Study to Evaluate the Long-term Safety, Tolerability and Efficacy of 2 Different Doses of Everolimus

Renal Transplantation

Switzerland
Novartis Pharmaceuticals

Completed

This is a 2-year Follow-up Study to Evaluate the Long-term Effects in Patients Who Completed the Study CRAD001A2307.

Renal Transplantation

Switzerland
Copenhagen University Hospital, Hvidovre
University of Copenhagen

Recruiting

Family Centred Healthcare - Zero Separation and Couplet Care

Premature Birth | Infant | Mother-Child Relations | Post Partum | Family

Denmark
Masonic Cancer Center, University of Minnesota

Withdrawn

Everolimus in Treating Women With Breast Cancer That Can Be Removed by Surgery

Breast Cancer

United States
Swiss Group for Clinical Cancer Research

Completed

Everolimus in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma

Lymphoma

France, Switzerland, Italy
Revance Therapeutics, Inc.

Completed

Safety Study of Two Repeat Doses of RT001 for the Treatment of Moderate to Severe Lateral Canthal Lines in Adults

Facial Wrinkles | Lateral Canthal Lines | Crow's Feet

United States

Search clinical trials for: Doublet (RAD001 and LBH589)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Jordan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations